Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-11-20

Clinical Trial Update: sPIF CLINICAL STUDY PROTOCOL IN AUTOIMMUNE HEPATITIS [Phase 1]

View source ↗

Summary

Phase 1 clinical trial protocol for sPIF in autoimmune hepatitis completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • sPIF

Snippet

Sponsor: Christopher O'Brien, MD | Conditions: Autoimmune Hepatitis | Phase 1 | Status: COMPLETED | Results posted: 2019-11-20